Status:
COMPLETED
Heterogeneity of Tertiary Lymphoid Structures Predicts Distinct Malignancy and Immune Microenvironment in Prostate Cancer: a Retrospective Cohort Study
Lead Sponsor:
Fudan University
Conditions:
Prostate Cancer
Eligibility:
MALE
Brief Summary
The aim of this study was to reveal the predictive value of spatial heterogeneity and maturity difference of tertiary lymphoid structure in pathological sections of prostate cancer patients for clinic...
Eligibility Criteria
Inclusion
- patients diagnosed with prostate cancer who underwent radical prostatectomy or prostate puncture
Exclusion
- 1\. incomplete medical records, inadequate follow-up information, and confirmed non-prostatic acinar adenocarcinoma.
Key Trial Info
Start Date :
December 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 30 2024
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06484127
Start Date
December 1 2023
End Date
May 30 2024
Last Update
July 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fudan University Shanghai Cancer Center
Shanghai, Shanghai Municipality, China, 200000